Powered by: Motilal Oswal
2024-12-18 02:45:42 pm | Source: Accord Fintech
Newgen Software rises on collaborating with Macquarie Health

Newgen Software Technologies is currently trading at Rs. 1503.70, up by 6.75 points or 0.45% from its previous closing of Rs. 1496.95 on the BSE.

The scrip opened at Rs. 1509.95 and has touched a high and low of Rs. 1515.00 and Rs. 1473.80 respectively. So far 12110 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1547.20 on 26-Sep-2024 and a 52 week low of Rs. 626.05 on 15-Apr-2024.

Last one week high and low of the scrip stood at Rs. 1515.00  and Rs. 1370.00 respectively. The current market cap of the company is Rs. 21044.47 crore.

The promoters holding in the company stood at 54.30%, while Institutions and Non-Institutions held 28.91% and 16.80% respectively.

Newgen Software Technologies has inked partnership with Macquarie Health (MQ Health), a leading healthcare organization affiliated with Macquarie University in Sydney. MQ Health, which brings together a hospital, clinical services, and research facilities, is dedicated to delivering advanced medical treatments and patient-centered care.

With this collaboration, MQ Health will replace its legacy document processing system with Newgen’s intelligent patient document processing system. The solution leverages AI/ML-powered document classification, data extraction, and workflow automation to streamline the management of patient documents. This will simplify access for healthcare professionals, ensure accuracy, and reduce administrative burdens. The system’s scalability will also support MQ Health’s growing needs, enabling them to adapt as their services expand.

Newgen Software Technologies is a software products company offering a platform that enables organisations to develop applications addressing their strategic business needs.

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here